Dexmedetomidine reduces sevoflurane EC(50) for supraglottic airway device insertion in spontaneously breathing morbidly obese patients

Purpose: This study aimed to assess the effect of intravenous dexmedetomidine (DEX) on sevoflurane EC(50) for supraglottic airway device (SAD) insertion in spontaneously breathing morbidly obese patients. Patients and methods: Thirty-eight morbidly obese patients with a body mass index 40–57 kg/m(2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Lei, Shao, Liu-Jia-Zi, Liu, Yang, Wang, Hai-Xia, Xue, Fu-Shan, Tian, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504637/
https://www.ncbi.nlm.nih.gov/pubmed/31118650
http://dx.doi.org/10.2147/TCRM.S199440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504637/
https://www.ncbi.nlm.nih.gov/pubmed/31118650
http://dx.doi.org/10.2147/TCRM.S199440

Ejemplares similares